FDA
-
-
-
-
-
-
-
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
-
-
-
-
-
-
-
Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products
-
-
-
-
-
-
-
Bio-Rad Labs (BIO) Announces SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization
-
-
-
-
-
-
-
Biodesix Partners with Bio-Rad (BIO) to Bring Emergency Use Authorization COVID-19 ddPCR Test to U.S.
-
-
-
-
-
-
-
Bio-Rad Reports Fourth-Quarter and Full-Year 2018 Financial Results
-
-
-
-
-
-
-
Bio-Rad Gains Additional U.S. FDA Clearances for Blood Typing Products, Expanding its Offering for the Blood Testing Market
-
-
-
-
-
-
-
Bio-Rad Introduces Enhanced Options with its IH-Com Data Management Software for Managing Patient Results with the IH-1000 System
-
329,545 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

